GGrantIndex
← Leaderboards

Merrill J Egorin

University Of Pittsburgh At Pittsburgh

$3,657,275
Attributed
$3,657,275
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.4M · FY200510
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10

Funding mix

By agency

NIH$3,657,275 · 5

By mechanism

N01$2,053,427 · 2
U01$914,153 · 1
P30$378,167 · 1
P41$311,528 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Others in their field

Top investigators on “Protein Isoforms

Research focus

Protein IsoformsCytochrome P450Drug KineticsLaboratoriesPharmacodynamicsBiologicalPharmaceutical PreparationsDrug MetabolismEnzymesMolecularDoseDesignMethodologyPharmacologyAnimalsProgramsMetabolismAntineoplastic AgentsPharmacokinetic ModelBiochemicalAnimal TissueClinical TrialsProtein BindingResearch Personnel

Grant awards (17)

Preclinical Pharmacological Studies of Antitumor & Other Therapeutic Agents$886,790
N01 · FY2010 · CA · contact PI
Preclinical Pharmacological Studies of Antitumor & Other Therapeutic Agents$509,715
N01 · FY2010 · CA · contact PI
Preclinical Pharmacological Studies of Antitumor & Other Therapeutic Agents$465,760
N01 · FY2009 · CA · contact PI
Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis$235,564
U01 · FY2009 · CA · contact PI
Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis$250,000
U01 · FY2008 · CA · contact PI
CORE--CLINICAL PHARMACOLOGY ANALYTICAL FACILITY$114,572
P30 · FY2008 · CA · contact PI
Phase I Clinical Trials of Novel Anticancer Agents$428,589
U01 · FY2007 · CA · contact PI
CORE--CLINICAL PHARMACOLOGY ANALYTICAL FACILITY$124,160
P30 · FY2007 · CA · contact PI
CORE--CLINICAL PHARMACOLOGY ANALYTICAL FACILITY$47,652
P30 · FY2006 · CA · contact PI
CORE--CLINICAL PHARMACOLOGY ANALYTICAL FACILITY$46,534
P30 · FY2005 · CA
CORE--CLINICAL PHARMACOLOGY ANALYTICAL FACILITY$45,249
P30 · FY2004 · CA
MODELING IN ANTI CANCER DRUG DVMT PRECLINICAL STUDIES THOUGH CLINICAL TRIALS$155,764
P41 · FY2002 · RR
MODELING IN ANTI CANCER DRUG DVMT PRECLINICAL STUDIES THOUGH CLINICAL TRIALS$155,764
P41 · FY2001 · RR
PRECLINICAL PHARMACOLOGICAL STUDIES OF ANTITUMOR AND ANT$159,302
N01 · FY2000 · CM
PRECLINICAL PHARMACOLOGICAL STUDIES OF ANTITUMOR AND ANT$31,860
N01 · FY2000 · CM
MODELING IN ANTI CANCER DRUG DVMT PRECLINICAL STUDIES THOUGH CLINICAL TRIALS$0
P41 · FY2000 · RR
PRECLINICAL PHARMACOLOGICAL STUDIES OF ANTITUMOR AND ANT$0
N01 · FY2000 · CM